PrintyMed

About the Company

PrintyMed develops biomimetic spider silk technologies for 3D bioprinting and medical devices. The company aims to harness the unique properties of this natural material to create innovative solutions for wound care, tissue regeneration, and artificial organs.

Technology

PrintyMed’s biomimetic spider silk technology combines biology, engineering, and creative design to produce a material that is strong, flexible, and biocompatible for medical applications.

Applications

Advanced wound care
Artificial organs and tissue engineering
Development of novel medical devices
Membranes for organ-on-a-chip technologies

Founding

PrintyMed was born from a shared vision to bridge the gap between real-world medical needs and the cutting-edge scientific research conducted at the Latvian Institute of Organic Synthesis. The company was founded in January 2023 by three co-founders with expertise in organic chemistry, business strategy, and medicine. Since its inception, PrintyMed has operated at the intersection of innovation and practical application, transforming scientific discoveries into solutions with tangible healthcare impact.

Contact

Phone: (+371) 28477969
E-mail: info@printymed.com
Homepage: https://www.printymed.com/